Romania - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry

Since 2014, Romania Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry fell by 7.3% year on year. In 2019, the country was ranked number 30 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry with $26,524,562.71 Million PPP. Romania is overtaken by Chile, which was number 29 at $28,786,954.1 Million PPP and is followed by Slovakia with $4,291,243.82 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, that is an increase of 3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.

Loading...

Date Million US Dollars PPP
2019 26,524,562.71
2018 26,181,292.20
2017 21,068,593.57
2016 36,967,447.64
2015 27,886,435.88
Download all data from 2004 to 2019

How does Romania rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?

# 69 Countries Million US Dollars PPP Last YoY 5‑years CAGR
1 #1
United States
70,565,318,932.39 2019 +3.3 % +4.5 % View data
2 #2
China
13,956,388,273.35 2019 +4.5 % +6.1 % View data
29 #29
Chile
28,786,954.10 2015 +2.7 % +15.9 % View data
30 #30
Romania
26,524,562.71 2019 +1.3 % -7.3 % View data
31 #31
Slovakia
4,291,243.82 2019 -17.4 % -13.2 % View data
Compare all 69 countries

Go Top